Tumor necrosis factor-α at the crossroads of neuronal life and death during HIV-associated dementia

Journal of Neurochemistry

Volumn 86, Issue 5, 2003, Pages 1057-1071

  Saha, Ramendra N ^a   Pahan, Kalipada ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Activation of glia; HIV dementia; Neurodegeneration; Neuroprotection; Nuclear factor kappa B; Tumor necrosis factor

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE; CASPASE 8; CHEMOKINE; CYSTEINE; GLUTAMIC ACID; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE B; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1; VIRUS PROTEIN; VPR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; BLOOD BRAIN BARRIER; CALCIUM HOMEOSTASIS; CELL TYPE; CONCEPT FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; REVIEW; SIGNAL TRANSDUCTION; THEORY; TRANSCRIPTION INITIATION; UPREGULATION; VIRUS TRANSMISSION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; RNA VIRUSES;

EID: 0041932218     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01942.x     Document Type: Review

References (121)

1. Adle-Biassette H., Levy Y., Colombel M., Poron F., Natchev S., Keohane C. and Gray F. (1995) Neuronal apoptosis in HIV infection in adults. Neurpathol. Appl. Neurobiol. 21, 218-227.
2. Adle-Biassette H., Chretien F., Wingertsmann L., Hery C., Ereau T., Scaravilli F., Tardieu M. and Gray F. (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25, 123-133.
3. Andjelkovic A. V., Kerkovich D., Shanley J., Pulliam L. and Pachter J. S. (1999) Expression of binding sites for β chemokines on human astrocytes. Glia 28, 225-235.
4. Asensio V. C. and Campbell I. L. (1999) Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22, 504-512.
5. Bal-Price A., Moneer Z. and Brown G. C. (2002) Nitric oxide induces rapid, calcium dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40, 312-323.
6. 2+ accumulation. Proc. Natl Acad. Sci. USA 92, 9328-9332.
7. Barna B. P., Estes M. L., Jacobs B. S., Hudson S. and Ransohoff R. M. (1990) Human astrocytes proliferate in response to tumor necrosis factor alpha. J. Neuroimmunol. 30, 239-243.
8. Barone F. C. and Parsons A. A. (2000) Therapeutic potential of anti-inflammatory drugs in focal stroke. Expert Opin. Invest. Drugs 9, 2281-2306.
9. Baud V. and Karin M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 11, 372-377.
10. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J. and Volterra A. (2001) CXCR4-activated astrocytes glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702-710.
11. Bhat N. R., Zhang P., Lee J. C. and Hogan E. L. (1998) Extracellular signal-regulated kinase and p38 sub-groups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
12. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P. and Lipton S. A. (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162-7166.
13. Bruce A. J., Boling W., Kindy M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W. and Mattson M. P. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2, 788-794.
14. Bruce-Keller A. J., Geddes J. W., Knapp P. E., McFall R. W., Keller J. N., Holtsberg F. W., Parthasarathy S., Steiner S. M. and Mattson M. P. (1999) Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J. Neuroimmunol. 93, 53-71.
15. Canki M., Potash M. J., Bentsman G., Chao W., Flynn T., Heinemann M., Gelbard H. and Volsky D. J. (1997) Isolation and long term culture of primary ocular human immunodeficiency virus type 1 isolates in primary astrocytes. J. Neurovirol. 3, 10-15.
16. Chao C. C., Hu S., Ehrlich L. and Peterson P. K. (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of NMDA receptors. Brain. Behav. Immun. 9, 355-365.
17. Chaparro-Huerta V., Rivera-Cervantes M. C., Torres-Mendoza B. M. and Beas-Zarate C. (2002) Neuronal death and tumor necrosis factor-alpha response to glutamate induced excitotoxicity in cerebral cortex of neonatal rats. Neurosci. Lett. 333, 95-98.
18. Chen G. and Goeddel D. V. (2002) TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635.
19. Chen Z. L. and Strickland S. (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917-925.
20. Cheng B., Christakos S. and Mattson M. P. (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
21. Combs C. K., Carlo C. J., Kao S. C. and Landret G. E. (2001) β-Amyloid stimulation of microglia and monocytes results in TNF-α dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188.
22. Cotter R., Williams C., Ryan L., Erichsen D., Lopez A., Peng H. and Zheng J. (2002) Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. J. Neurovirol. 8, 1-14.
23. Cutler R. G. and Mattson M. P. (2001) Sphingomyelin and ceramide as regulators of development and lifespan. Mech. Ageing Dev. 122, 895-908.
24. Diem R., Meyer R., Weishaupt J. H. and Bahr M. (2001) Reduction of potassium currents and Phosphoinositol 3-kinase-dependent Akt phosphorylation by tumor necrosis factor-α rescues axotomized retinal ganglion cells from retrograde cell death. J. Neurosci. 21, 2058-2066.
25. Diesing T. S., Swindells S., Gelbard H. and Gendelman H. E. (2002) HIV-associated dementia: a basic science and clinical perspective. AIDS Read. 12, 358-368.
26. Dreyer E. B., Kaiser P. K., Offermann J. T. and Lipton S. A. (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248, 364-367.
27. Dugas N., Lacroix C., Kilchherr E., Delfraissy J. F. and Tardieu M. (2001) Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. Cytokine 15, 96-107.
28. Fiala M., Looney D. J., Stins M., Way D. D., Zhang L., Gan X., Chiappelli F., Schweitzer E. S., Shapshak P., Weinand M., Graves M. C., Witte M. and Kim K. S. (1997) TNF-alpha opens a paracellular route for HIV invasion across blood brain barrier. Mol. Med. 3, 553-564.
29. Fine S. M., Angel R. A., Perry S. W., Epstein L. G., Rothstein J. D., Dewhurst S. and Gelbard H. A. (1996) Tumor necrosis factor-α inhibits glutamate uptake by primary human astrocytes: implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271, 15303-15306.
30. Fontana G., Valenti L. and Raiteri M. (1997) gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J. Neurosci. Res. 49, 732-738.
31. Foos T M. and Wu J. Y. (2002) The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem. Res. 27, 21-26.
32. Fotin-Mleczek M., Henkler F., Samel D., Reichwein M., Hausser A., Parmryd I., Scheurich P., Schmid J. A. and Wajant H. (2002) Apoptotic crosstalk of TNF receptors: TNF-R2 induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1 dependent activation of caspase-8. J. Cell. Sci. 115, 2757-2770.
33. Furukawa K. and Mattson M. P. (1998) The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-α in hippocampal neurons. J. Neurochem. 70, 1876-1886.
34. Garden G. A. (2002) Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40, 240-251.
35. Garden G. A., Budd S. L., Tsai E., Hanson L., Kaul M., D'Emilia D. M., Friedlander R. M., Yuan J., Masliah E. and Lipton S. A. (2002) Caspase cascade in human immunodeficiency virus associated neurodegeneration. J. Neurosci. 22, 4015-4024.
36. Gartner S. (2000) HIV infection and dementia. Science 287, 602-604.
37. Gary D. S., Bruce-Keller A., Kindy M. S. and Mattson M. P. (1998) Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18, 1283-1287.
38. Gelbard H. A. (1999) Neuroprotective strategies for HIV-1-associated neurologic disease. Ann. New York Acad. Sciences 890, 312-313.
39. Gendelman H. E., Zheng J., Coulter C. L., Ghorpade A., Che M., Thylin M., Rubocki R., Persidsky Y., Hahn F., Reinhard J. Jr and Swindells S. (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178, 1000-1007.
40. Ghosh S., May M. J. and Kopp E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
41. Ginis I., Jaiswal R., Klimanis D., Liu J., Greenspon J. and Hallenbeck J. M. (2002) TNF-α-induced tolerance to ischemic injury involves differential control of NF-κB transactivation: role of NF-κB association with p300 adapter. J. Cereb. Blood Flow Metab. 22, 142-152.
42. Giulian D., Wendt E., Vaca K. and Noonan C. A. (1993) The envelope glycoprotein of HIV-1 stimulates release of neurotoxins from monocytes. Proc. Natl Acad. Sci. USA 90, 2769-2773.
43. Glass J. D. and Johnson R. T. (1996) Human immunodeficiency virus and the brain. Annu. Rev. Neurosci. 19, 1-26.
44. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adle-Biassette H., Wingertsmann L., Durigon M., Hurtrel B., Chiodi F., Bell J. and Lantos P. (1996) Neuropathology of early HIV-1 infection. Brain Pathol. 6, 1-15.
45. Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G. and Pfizenmaier K. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 KDa tumor necrosis factor receptor. Cell 83, 793-802.
46. Griffin D. E. (1997) Cytokines in the brain during viral infection: clues to HIV-associated dementia. J. Clin. Invest. 100, 2948-2951.
47. Guo H., Jin Y. X., Ishikawa M., Huang Y. M., van der Meide P. H., Link H. and Xiao B. G. (1998) Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand. J. Immunol. 48, 502-508.
48. Gupta S. (2002) A decision between life and death during TNFα signaling. J. Clin. Immunol. 22, 185-194.
49. Hallenbeck J. M. (2002) Many faces of tumor necrosis factoring stroke. Nat. Med. 8, 1363-1368.
50. Han Y., He T., Huang D. R., Pardo C. A. and Ransohoff R. M. (2001a) TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J. Clin. Invest, 108, 425-435.
51. Han Y, Wang J., He T. and Ransohoff R. M. (2001b) TNFα down regulates CXCR4 expression in primary murine astrocytes. Brain Res. 888, 1-10.
52. Haviv R. and Stein R. (1999) Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells. J. Neurosci. Res. 55, 269-277.
53. Houzen H., Kikuchi S., Kanno M., Shinpo K. and Tashiro K. (1997) Tumor necrosis factor enhances outward potassium currents in cultured rat cortical neuron. J. Neurosci. Res. 50, 990-999.
54. Hu S., Sheng W. S., Ehrlich L. C., Peterson P. K. and Chao C. C. (2000) Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7, 153-159.
55. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B. and Hirsch E. C. (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440-3447.
56. Kast R. E. (2002-2003) Feedback between glial tumor necrosis factor-alpha and gp-120 from HIV-infected cells helps maintain infection and destroy neurons. Neuroimmunomodulation 10, 85-92.
57. Kaul M. and Lipton S. A. (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl Acad. Sci. USA 96, 8212-8216.
58. Kaul M., Garden G. A. and Lipton S. A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
59. Kim G.-M., Xu J., Xu J., Song S.-K., Yan P., Ku G., Xu X.M. and Hsu C. Y. (2001) Tumor necrosis factor deletion reduces factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci 21, 6617-6625.
60. Kolson D. L. and Gonzalez-Scarano F. (2000) HIV and HIV dementia. J. Clin. Invest. 106, 11-13.
61. Langford D. and Masliah E. (2001) Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 11, 306-312.
62. Lawrence D. M. and Major E. O. (2002) HIV-1 and the brain: connection between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect. 4, 301-308.
63. Lee S. J., Hou J. and Benveniste E. N. (1998) Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-kappaB and C/EBP isoforms. J. Immunol. 92, 196-207.
64. Letendre S. L., Lanier E. R. and McCutchan J. A. (1999) Cerebrospinal fluid beta chemokine concentration in neurocognitivity impaired individuals infected with human immunodeficiency virus type 1. J. Infect. Dis. 180, 310-319.
65. Lipton S. A. (1998) Neuronal injury associated with HIV-1: approaches to treatment. Annu. Rev. Pharmacol. Toxicol. 38, 159-177.
66. Lipton S. A. and Gendelman H. E. (1995) Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332, 934-940.
67. Liu X., Jana M., Dasgupta S., Koka S., He J., Wood C. and Pahan K. (2002) Human immunodeficiency virus type-1 (HIV-1) tat induces nitric oxide synthase in human astroglia. J. Biol. Chem. 277, 39312-39319.
68. Lung H. L., Leung K. N., Stadlin A., Ma C. M. and Tsang D. (2001) Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes. Life Sci. 68, 2081-2091.
69. MacEwan D. J. (2002) TNF receptor subtype signaling: differences and cellular consequences. Cell. Signal. 14, 477-492.
70. Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M. and Nath A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373-380.
71. Mattson M. P. and Camandola S. (2001) NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254.
72. Mattson M. P., Culmsee C. YuZ. and Camandola S. (2000) Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74, 443-456.
73. McManus C. M., Brosnan C. F. and Berman J. W. (1998) Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J. Immunol. 160, 1449-1455.
74. Medvedev A. E., Espevik T., Ranges G. and Sundan A. (1996) Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects. J. Biol. Chem. 271, 9778-9784.
75. Moosmayer D., Dinkel A., Gerlach E., Hessabi B., Grell M., Pfizenmaier K. and Scheurich P. (1994) Coexpression of the human TNF receptors TR60 and TR80 in insect cells: analysis of receptor complex formation. Lymphokine Cytokine Res. 13, 295-301.
76. Nadeau S. and Rivest S. (1999) Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93, 1449-1464.
77. Nagatsu T., Mogi M., Ichinose H. and Togari A. (2000) Cytokines in Parkinson's disease. J. Neural Transm. Suppl. 58, 143-151.
78. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N. and Geiger J. D. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70, 1475-1480.
79. Nicholas R. S., Compston A. and Brown D. R. (2001) Inhibition of tumour necrosis factor-α induced NF-κB p52 converts the metabolic effects of microglial-derived TNF- α on mouse cerebellar neurons to neurotoxicity. J. Neurochem. 76, 1431-1438.
80. Pahan K., Dobashi K., Ghosh B. and Singh I. (1999) Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide. J. Neurochem. 73, 513-520.
81. ras inhibits induction of nitric oxide synthase and activation of nuclear factor-κB in primary astrocytes. J. Neurochem. 74, 2288-2295.
82. Pahan K., Sheikh F. G., Liu X., Hilger S., McKinney M. and Petro T. M. (2001) Induction of nitric-oxide synthase and activation of NF-kappa B by interleukin-12 p40 in microglial cells. J. Biol. Chem. 276, 7899-7905.
83. Patel C. A., Mukhtar M. and Pomerantz R. J. (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol. 74, 9717-9726.
84. Perry R. T., Collins J. S., Wiener H., Acton R. and Go R. C. (2000) The role of TNF and its receptors in Alzheimer's disease. Neurobiol. Aging 22, 873-883.
85. Perry S. W., Dewhurst S., Bellizzi M. J. and Gelbard H. A. (2002) Conflicting effects of TNFα in normal and diseased brain: intraneural receptor crosstalk as one of the mechanism for explaining the paradox. J. Neurovirol. 8, 611-624.
86. Persidsky Y. and Gendelman H. E. (2002) Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms. J. Neurovirol. 8, 49-52.
87. Petito C. K., Vecchio D. and Chen Y.-T. (1994) HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. J. Neuropathol. Exp. Neurol. 53, 86-94.
88. Pimentel-Muinos F. X. and Seed B. (1999) Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11, 783-793.
89. Pulliam L., Zhou M., Stubblebine M. and Bitler C. M. (1998) Differential modulation of cell death proteins in human brain cells by TNF alpha and platelet activating factor. J. Neurosci. Res. 54, 530-538.
90. Quasney M. W., Zhang Q., Sargent S., Mynatt M., Glass J. and McArthur J. (2001) Increased frequency of the TNFα-308A allele in adults with HIV dementia. Ann. Neurol. 50, 157-162.
91. Reimann-Philipp U., Ovase R., Weigel P. H. and Grammas P. (2001) Mechanism of cell death in primary cortical neurons and PC12 cells. J. Neurosci. Res. 64, 654-660.
92. Rose-John S. and Heinrich P. C. (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
93. Rousselet E., Callebert J., Parain K., Joubert C., Hunot S., Hartmann A., Jacque C., Perez-Diaz F., Cohen-Salmon C., Launay J. M. and Hirsch E. C. (2002) Role of TNF-α receptors in mice intoxicated with the parkinsonian toxin MPTP. Exp. Neurol. 177, 183-192.
94. Sapolsky R. M. (2001) Cellular defense against excitotoxic insults. J. Neurochem. 76, 1601-1611.
95. Schlomann U., Rathke-Hartlieb S., Yamamoto S., Jockusch H. and Bartsch J. W. (2000) Tumor necrosis factor α induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J. Neurosci. 20, 7964-7971.
96. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T. and Schwaninger M. (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559.
97. Segui B., Cuvillier O., Adam-Klages S., Garcia V., Malagarie-Cazenave S., Leveque S., Caspar-Bauguil S., Coudert J., Salvayre R., Kronke M. and Levade T. (2001) Involvement of FAN in TNF-induced apoptosis. J. Clin. Invest. 108, 143-151.
98. Shi B., De Girolami U., He J., Wang S., Lorenzo A., Busciglio J. and Gabuzda D. (1996) Apoptosis induced by HIV-1 infection of central nervous system. J. Clin. Invest. 98, 1979-1990.
99. Shi B., Raina J., Lorenzo A., Busciglio J. and Gabuzda D. (1998) Neuronal apoptosis induced by Hiv-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV dementia. J. Neurovirol. 4, 281-290.
100. Sippy B. D., Hofman F. M., Wallach D. and Hinton D. R. (1995) Increased expression of TNF-alpha receptors in the brain of patients with AIDS. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10, 511-521.
101. Sriram K., Matheson J. M., Benkovic S. A., Miller D. B., Luster M. I. and O'Callaghan J. P. (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16, 1474-1476.
102. Talley A. K., Dewhurst S., Perry S. W., Dollard S. C., Gummuluru S., Fine S. M., New D., Epstein L. G., Gendelman H. E. and Gelbard H. A. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by antioxidant N-acetylcysteine and genes bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366.
103. Tamatani M., Che Y. H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T. and Tohyama M. (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκ3 activation in primary hippocampal neurons. J. Biol. Chem. 274, 8531-8538.
104. Tarkowski E., Blennow K., Wallin A. and Tarkowski A. (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer's disease and vascular dementia. J. Clin. Immunol. 19, 223-230.
105. Torres-Munoz J., Stockton P., Tacoronte N., Roberts B., Maronpot R. R. and Petito C. K. (2001) Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 60, 885-892.
106. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L. and Griffin D. E. (1992) Cytokine expression in the brain during acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360.
107. Tyor W. R., Wesselingh S. L., Griffin J. W., McArthur J. C. and Griffin D. E. (1995) Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9, 379-388.
108. Vandenabeele P., Declercq W., Vanhaesebroeck B., Grooten J. and Fiers W. (1995) Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154, 2904-2913.
109. Veerhuis R., Hoozemans J. J., Janssen I., Boshuizen R. S., Langeveld J. P. and Eikelenboom P. (2002) Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2. Brain Res. 925, 195-203.
110. Venters H. D., Tang Q., Liu Q., VanHoy R. W., Dantzer R. and Kelley K. W. (1999) A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by survival peptide. Proc. Natl Acad. Sci. USA 96, 9879-9884.
111. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339-343.
112. Wang C. X. and Shuaib A. (2002) Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 67, 161-172.
113. Wesselingh S. L., Power C., Glass J. D., Tyor W. R., McArthur J. C., Farber J. M., Griffin J. W. and Griffin D. E. (1993) Intracerebral cytokine mRNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33, 576-582.
114. Wilde G. J., Pringle A. K., Sundstrom L. E., Mann D. A. and Iannotti F. (2000) Attenuation and augmentation of ischaemia-related neuronal death by tumor necrosis factor-alpha in vitro. Eur. J. Neurosci. 12, 3863-3870.
115. Xu L., Zhan Y., Wang Y., Feuerstein G. Z. and Wang X. (2002) Recombinant adenoviral expression of dominant negative IkappaB-alpha protects brain from cerebral ischemic injury. Biochem. Biophys. Res. Commun. 299, 14-17.
116. Yang L., Lindholm K., Konishi Y., Li R. and Shen Y. (2002) Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J. Neurosci. 22, 3025-3032.
117. Yeh M. W., Kaul M., Zheng J., Nottet H. S., Thylin M., Gendelman H. E. and Lipton S. A. (2000) Cytokine stimulated, but not HIV-infected human monocyte derived macrophages produce neurotoxic levels of 1-cysteine. J. Neuroimmunol. 164, 4265-4270.
118. Yoshida H., Imaizumi T., Fujimoto K., Matsuo N., Kimura K., Cui X., Matsumiya T., Tanji K., Shibata T. and Tamo W. (2001) Synergistic stimulation by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci. Lett. 303, 132-136.
119. Zheng J., Thylin M. R., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y. C., Gelbard H. A., Shepard R. B., Swartz J. M. and Gendelman H. E. (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-associated dementia. J. Neuroimmunol. 98, 185-200.
120. Yu Z., Zhou D., Bruce-Keller A. J., Kindy M. S. and Mattson M. P. (1999) Lack of p50 subunit of nuclear factor-κB increases vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19, 8856-8865.
121. Yu Z., Zhou D., Cheng G. and Mattson M. P. (2000) Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease. J. Mol. Neurosci. 15, 31-44.